Are a high-refined carbohydrate diet and the alterations resulting from its intake linked to small intestine changes?

FHS
June 27, 2023
10:02 am

Researchers investigated whether a high-refined carbohydrate diet and associated metabolic alterations could cause small intestinal dysregulation.

Spexis announces engagement with Maxim Group LLC as M&A advisor to support evaluation of strategic transactions – Biotech Investments

Spexis AG / Key word(s): Strategic Company Decision 30-Jun-2023 / 07:15 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer

July 1, 2023

Merck winds down TIGIT, LAG-3 programs meant to temper Keytruda erosion

After multiple clinical failures, it’s finally the end of the road for Merck’s TIGIT program. The company is dropping development of its anti-TIGIT candidate vibostolimab

December 18, 2024

Amgen starts late-stage studies of MariTide

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. My colleagues

March 6, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.